Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (8): 681-683.DOI: 10.3969/j.issn.1673-8640.2016.08.011
• Orginal Article • Previous Articles Next Articles
Received:2015-07-03
Online:2016-08-31
Published:2016-09-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.08.011
| 组别 | 例数 | 术后第1天 | 术后第3天 | |||
|---|---|---|---|---|---|---|
| DD（mg/L） | FM（mg/L） | DD（mg/L） | FM（mg/L） | |||
| 并发DVT组 | 9 | 3.83±1.82* | 21.37±6.28*# | 11.99±2.64* | 86.1±48.80*# | |
| 未并发DVT组 | 51 | 1.08±0.96 | 10.77±4.75# | 1.66±1.01 | 13.33±5.63# | |
| 组别 | 例数 | 术后第1天 | 术后第3天 | |||
|---|---|---|---|---|---|---|
| DD（mg/L） | FM（mg/L） | DD（mg/L） | FM（mg/L） | |||
| 并发DVT组 | 9 | 3.83±1.82* | 21.37±6.28*# | 11.99±2.64* | 86.1±48.80*# | |
| 未并发DVT组 | 51 | 1.08±0.96 | 10.77±4.75# | 1.66±1.01 | 13.33±5.63# | |
| 术后第1天 | 例数 | DD（mg/L） |
|---|---|---|
| A | 17 | 0.39±0.08 |
| B | 9 | 0.39±0.09 |
| 术后第1天 | 例数 | DD（mg/L） |
|---|---|---|
| A | 17 | 0.39±0.08 |
| B | 9 | 0.39±0.09 |
| [1] | DOUKETIS J,TOSETTO A,MARCUCCI M,et al.Patient-level meta-analysis:effect of measurement timing,threshold,and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism[J]. Ann Intern Med,2010,153(8):523-531. |
| [2] | OSHIRO A,YANAGIDA Y,GANDO S,et al.Hemostasis during the early stages of trauma:comparison with disseminated intravascular coagulation[J]. Crit Care,2014,18(2):R61. |
| [3] | SATHE PM,PATWA UD.D dimer in acute care[J]. Int J Crit Illn Inj Sci,2014,4(3):229-232. |
| [4] | HOU H,GE Z,YING P,et al.Biomarkers of deep venous thrombosis[J]. J Thromb Thrombolysis,2012,34(3):335-346. |
| [5] | TANAKA KA,KEY NS,LEVY JH.Blood coagulation:hemostasis and thrombin regulation[J]. Anesth Analg,2009,108(5):1433-1446. |
| [6] | WADA H,SAKURAGAWA N.Are fibrin-related markers useful for the diagnosis of thrombosis?[J]. Semin Thromb Hemost,2008,34(1):33-38. |
| [7] | SCHUTGENS RE,HAAS FJ,AGTEROF MJ,et al.The role of fibrin monomers in optimizing the diagnostic work-up of deep vein thrombosis[J]. Thromb Haemost,2007,97(5):807-813. |
| [8] | PARK KJ,KWON EH,KIM HJ,et al.Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation[J]. Korean J Lab Med,2011,31(3):143-147. |
| [9] | BYKYILMAZ F,SENDIR M,AUTAR R,et al.Risk level analysis for deep vein thrombosis(DVT):a study of Turkish patients undergoing major orthopedic surgery[J]. J Vasc Nurs,2015,33(3):100-105. |
| [10] | LEE SY,RO DU H,CHUNG C,et al.Incidence of deep vein thrombosis after major lower limb orthopedic surgery:analysis of a nationwide claim registry[J]. Yonsei Med J,2015,56(1):139-145. |
| [11] | ZENG Y,SHEN B,YANG J,et al.Preoperative comorbidities as potential risk factors for venous thromboembolism after joint arthroplasty:a systematic review and meta-analysis of cohort and case-control studies[J]. J Arthroplasty,2014,29(12):2430-2438. |
| [12] | OGER E.Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale[J]. Thromb Haemost,2000,83(5):657-660. |
| [13] | SPENCER FA,EMERY C,LESSAR D,et al.The Worcester Venous Thromboembolism Study:a population-based study of the clinical epidemiology of venous thromboembolism[J]. J Gen Intern Med,2006,21(7):722-727. |
| [14] | WELLS PS,ANDERSON DR,RODGER M,et al.Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis[J]. N Engl J Med,2003,349(13):1227-1235. |
| [15] | COSMI B,LEGNANI C,TOSETTO A,et al.Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism:the PROLONG Ⅱ prospective study[J]. Blood,2010,115(3):481-488. |
| [16] | BECATTINI C,LIGNANI A,MASOTTI L,et al.D-dimer for risk stratification in patients with acute pulmonary embolism[J]. J Thromb Thrombolysis,2011,33(1):48-57. |
| [17] | OWAIDAH T,ALGHASHAM N,ALGHAMDI S,et al.Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of venous thromboembolism by medical residents[J]. Thromb J,2014,12(1):28. |
| [18] | YAMAKI T,NOZAKI M,SAKURAI H,et al.Combined use of pretest clinical probability score and latex agglutination D-dimer testing for excluding acute deep vein thrombosis[J]. J Vasc Surg,2009,50(5):1099-1105. |
| [19] | DOPSAJ V,BOGAVAC-STANOJEVIC N,VASIC D,et al.Excluding deep venous thrombosis in symptomatic outpatients:is fibrin monomer aid to D-dimer analysis?[J]. Blood Coagul Fibrinolysis,2009,20(7):546-551. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
